5KAO

Crystal structure of wild type HIV-1 protease in complex with GRL-10413

5KAO の概要

• エントリーDOI: 10.2210/pdb5kao/pdb
• 関連するPDBエントリー: 4HLA
• 分子名称: protease, [(3~{a}~{S},4~{R},6~{a}~{R})-2,3,3~{a},4,5,6~{a}-hexahydrofuro[2,3-b]furan-4-yl] ~{N}-[(2~{S},3~{R})-1-(3-chloranyl-4-methoxy-phenyl)-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-3-oxidanyl-butan-2-yl]carbamate (3 entities in total)
• 機能のキーワード: grl-10413, hiv-1 protease, protease-inhibitor, darunavir, 2-chloroanisole, nonpeptidic, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
• 由来する生物種: Human immunodeficiency virus 1
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 22078.34

構造登録者

Yedidi, R.S.,Delino, N.S.,Das, D.,Kaufman, J.D.,Wingfield, P.T.,Ghosh, A.K.,Mitsuya, H. (登録日: 2016-06-01, 公開日: 2016-08-31, 最終更新日: 2023-09-27)

• 主引用文献: Amano, M.,Salcedo-Gomez, P.M.,Zhao, R.,Yedidi, R.S.,Das, D.,Bulut, H.,Delino, N.S.,Sheri, V.R.,Ghosh, A.K.,Mitsuya, H.; A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413.; Antimicrob.Agents Chemother., 60:7046-7059, 2016; PubMed: 27620483; DOI: 10.1128/AAC.01428-16

実験手法